These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 9703941)
1. In vitro toxicity of A 3'-azido-3'-deoxythymidine and hydroxyurea combination on normal myeloid progenitors. Lerza R; Castello G; Ballarino P; Mela GS; Tredici S; Arboscello E; Mencoboni M; Pannacciulli I Anticancer Res; 1998; 18(4A):2755-8. PubMed ID: 9703941 [TBL] [Abstract][Full Text] [Related]
2. The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells. Bhalla K; Birkhofer M; Grant S; Graham G Exp Hematol; 1989 Jan; 17(1):17-20. PubMed ID: 2783247 [TBL] [Abstract][Full Text] [Related]
3. The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors. Grillon C; Bonnet D; Mary JY; Lenfant M; Najman A; Guigon M Stem Cells; 1993 Sep; 11(5):455-64. PubMed ID: 8241956 [TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity. Mayhew CN; Phillips JD; Greenberg RN; Birch NJ; Elford HL; Gallicchio VS Stem Cells; 1999; 17(6):345-56. PubMed ID: 10606163 [TBL] [Abstract][Full Text] [Related]
5. Hemotoxic effects on mice of combined administration of azidothymidine and acyclovir. Bogliolo G; Lerza R; Mencoboni M; Flego G; Gasparini L; Pannacciulli I Exp Hematol; 1991 Sep; 19(8):838-41. PubMed ID: 1868898 [TBL] [Abstract][Full Text] [Related]
6. In vitro synergistic inhibition of human bone marrow hemopoietic progenitor growth by a 3'-azido-3'-deoxy-thymidine, 2',3'-dideoxycytidine combination. Lerza R; Castello G; Mela GS; Arboscello E; Cerruti A; Bogliolo G; Mencoboni M; Ballarino P; Pannacciulli I Exp Hematol; 1997 Mar; 25(3):252-5. PubMed ID: 9091302 [TBL] [Abstract][Full Text] [Related]
7. Differential toxicity of carbovir and AZT to human bone marrow hematopoietic progenitor cells in vitro. Kurtzberg J; Carter SG Exp Hematol; 1990 Nov; 18(10):1094-6. PubMed ID: 2209763 [TBL] [Abstract][Full Text] [Related]
9. Myelotoxicity of rifabutin and 3'-azido-3'-deoxythymidine, alone and in combination, to human hematopoietic progenitor cells in vitro. Volpe DA; Du DL; Verhoef V; Murphy MJ Pathobiology; 1993; 61(2):77-82. PubMed ID: 8216829 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice. Prakash O; Rodriguez VE; Tang ZY; Zhou P; Coleman R; Dhillon G; Shellito JE; Nelson S Alcohol Clin Exp Res; 2001 Mar; 25(3):450-6. PubMed ID: 11290858 [TBL] [Abstract][Full Text] [Related]
11. Azidothymidine and interferon-alpha in vitro effects on hematopoiesis: protective in vitro activity of IL-1 and GM-CSF. Castello G; Mela G; Cerruti A; Mencoboni M; Lerza R Exp Hematol; 1995 Dec; 23(13):1367-71. PubMed ID: 7498365 [TBL] [Abstract][Full Text] [Related]
12. Role of human serum and cellular factors on the growth of peripheral blood CFU-gm. Bellone G; Lista P; Veglia F; Pegoraro L; Lista L Int J Cell Cloning; 1987 Nov; 5(6):463-71. PubMed ID: 3429932 [TBL] [Abstract][Full Text] [Related]
13. Synergistic bone marrow toxicity of pyrimethamine and zidovudine in murine in vivo and in vitro models: mechanism of toxicity. Freund YR; Dabbs J; Creek MR; Phillips SJ; Tyson CA; MacGregor JT Toxicol Appl Pharmacol; 2002 May; 181(1):16-26. PubMed ID: 12030838 [TBL] [Abstract][Full Text] [Related]
14. Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on normal human bone marrow progenitor cells. Berman E; Duigou-Osterndorf R; Krown SE; Fanucchi MP; Chou J; Hirsch MS; Clarkson BD; Chou TC Blood; 1989 Sep; 74(4):1281-6. PubMed ID: 2765664 [TBL] [Abstract][Full Text] [Related]
15. Increased therapeutic efficacy of zidovudine in combination with vitamin E. Gogu SR; Beckman BS; Rangan SR; Agrawal KC Biochem Biophys Res Commun; 1989 Nov; 165(1):401-7. PubMed ID: 2590237 [TBL] [Abstract][Full Text] [Related]
16. Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements. Gillespie D; Hubbell HR; Carter WA; Midgette P; Elsasser W; Mullaney R; Strayer DR In Vivo; 1994; 8(3):375-81. PubMed ID: 7803722 [TBL] [Abstract][Full Text] [Related]
17. Selective protection of toxicity of 2',3'-dideoxypyrimidine nucleoside analogs by beta-D-uridine in human granulocyte-macrophage progenitor cells. Faraj A; Schinazi RF; Xie MY; Gosselin G; Perigaud C; Imbach JL; Sommadossi JP Antiviral Res; 1996 Mar; 29(2-3):261-7. PubMed ID: 8739604 [TBL] [Abstract][Full Text] [Related]
18. Protection of 3'-azido-3'-deoxythymidine induced toxicity to murine hematopoietic progenitors (CFU-GM, BFU-E and CFU-MEG) with interleukin-1. Gallicchio VS; Doukas MA; Hulette BC; Hughes NK; Gass C Proc Soc Exp Biol Med; 1989 Nov; 192(2):201-4. PubMed ID: 2813453 [TBL] [Abstract][Full Text] [Related]
19. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro. Korycka A; Robak T Arch Immunol Ther Exp (Warsz); 2003; 51(1):61-7. PubMed ID: 12691305 [TBL] [Abstract][Full Text] [Related]
20. In vitro toxicity of trichothecenes on human haematopoietic progenitors. Parent-Massin D; Fuselier R; Thouvenot D Food Addit Contam; 1994; 11(4):441-7. PubMed ID: 7958114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]